Article
Erythropoietin Receptor Signaling through STAT3 Is Required for Glioma Stem Cell Maintenance
1 Jan 2010
Abstract excerpt
Recombinant erythropoietin (EPO) is a growth factor used in the treatment of chemotherapy-induced anemia, but recent studies suggest that EPO may accelerate cancer growth. Although several cancers express EPO receptors (EPORs), the mechanism by which EPOR promotes tumor growth remains poorly understood. Glioblastomas display a cellular hierarchy of self-renewal and tumor propagation restricted to glioma stem...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
